Aurinia Announces Updates to the Board of Directors - businesswire.com -BoardProspects

Aurinia Announces Updates to the Board of Directors

businesswire.com Nov 14 2019 BoardMoves

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple inflammatory and autoimmune conditions, today announced the appointment of Ms. Jill Leversage to its Board of Directors and the resignation of Dr. Hyeuk Joon Lee...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- NASDAQ OMX Reports Record Fourth Quarter 2013 Results also mentions Nasdaq
- BMC’s Independent, Experienced Board Overseeing Continued Growth and Value Creation also published in businesswire.com
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- Accomplished Lawyer Returns to Fulbright's Houston Office also published in businesswire.com
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- USA Technologies’ Board of Director Nominees Underscore Company’s Commitment to Excellence and Superior Performance also published in businesswire.com
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned